DHC Acquisition Corp. Announces Change of Date and Time of its Shareholder Meeting
November 28 2023 - 6:00AM
Business Wire
DHC Acquisition Corp (Nasdaq: DHCA) (the “Company” or
“DHC”), a special purpose acquisition company sponsored by
DHC Sponsor LLC, announced today that its extraordinary general
meeting of shareholders (“Shareholder Meeting”) will be
postponed from its scheduled date of 9:00 a.m. Eastern Time on
November 30, 2023 to 9:00 a.m. Eastern Time on December 1, 2023.
The Shareholder Meeting can still be accessed virtually by visiting
https://www.cstproxy.com/dhcacquisition/egm2023. You will need the
meeting control number that is printed on your proxy card to enter
the Shareholder Meeting. The record date for the Shareholder
Meeting remains November 16, 2023.
The Company filed the original definitive proxy statement (the
“Proxy Statement”) in connection with the Shareholder
Meeting with the U.S. Securities and Exchange Commission (the
“SEC”) on November 16, 2023.
Shareholders who have previously submitted their proxies or
otherwise voted and who do not want to change their vote need not
take any action. Shareholders as of the record date can vote, even
if they have subsequently sold their shares. Any shareholders who
wish to change their vote and need assistance should contact Morrow
Sodali LLC at (800) 662-5200, or
DHCA.info@investor.morrowsodali.com. In connection with the
postponement of the Shareholder Meeting, DHC has extended the
deadline for holders of DHC’s Class A ordinary shares issued in
DHC’s initial public offering (the “Public Shares”) to
submit their Public Shares for redemption in connection with the
Charter Extension (as defined in the Proxy Statement) until 5:00
p.m. Eastern Time on November 30, 2023. Shareholders who wish to
withdraw their previously submitted redemption requests may do so
prior to the rescheduled meeting by requesting that the transfer
agent return such Public Shares prior to 6:30 a.m. Eastern Time on
December 1, 2023.
Important Information About the Transactions and Where to
Find It
DHC has filed the Proxy Statement with the SEC in connection
with the Shareholder Meeting to consider and vote upon the
Extension Amendment Proposal and other matters and, beginning on or
about November 20, 2023, mailed the Proxy Statement and other
relevant documents to its stockholders as of the November 16, 2023
record date for the Shareholder Meeting. DHC’s shareholders and
other interested persons are advised to read, when available, the
preliminary proxy statement and any amendments thereto and the
Proxy Statement and documents incorporated by reference therein
filed in connection with the Transactions, as these materials will
contain important information about DHC, the Extension Amendment
Proposal and related matters. Shareholders may also obtain copies
of the Proxy Statement and other documents filed with the SEC that
will be incorporated by reference therein, without charge, at the
SEC’s website at www.sec.gov, or by directing a request to: DHC
Acquisition Corp., 1900 West Kirkwood Blvd, Suite 1400B, Southlake,
TX 76092 or by emailing chris@integrity.partners.
Participants in the Solicitation
DHC and its directors and executive officers may be deemed
participants in the solicitation of proxies from DHC’s shareholders
with respect to the Shareholder Meeting, the Extension Amendment
Proposal (as defined in the Proxy). A list of the names of those
directors and executive officers and a description of their
interests in DHC is contained in DHC’s annual report on Form 10-K
for the fiscal year ended December 31, 2022, which was filed with
the SEC on March 30, 2022 and is available at the SEC’s website at
www.sec.gov, or by directing a request to: DHC Acquisition Corp.,
1900 West Kirkwood Blvd, Suite 1400B, Southlake, TX 76092 or by
emailing chris@integrity.partners. Additional information regarding
the interests of such participants is contained in the Proxy
Statement.
Forward-Looking Statements
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934 that are not historical
facts, and involve risks and uncertainties that could cause actual
results of DHC to differ materially from those expected and
projected. These forward-looking statements can be identified by
the use of forward-looking terminology, including the words
“believes,” “estimates,” “anticipates,” “expects,” “intends,”
“plans,” “may,” “will,” “potential,” “projects,” “predicts,”
“continue,” or “should,” or, in each case, their negative or other
variations or comparable terminology. These forward-looking
statements include, without limitation, statements regarding the
estimated per share redemption price and related matters.
These forward-looking statements involve significant risks and
uncertainties that could cause the actual results to differ
materially from the expected results. Most of these factors are
outside DHC’s control and are difficult to predict. Factors that
may cause such differences include those set forth in the “Risk
Factors” section of DHC’s Annual Report on Form 10-K, subsequent
quarterly reports on Form 10-Q and initial public offering
prospectus.
DHC cautions readers not to place undue reliance upon any
forward-looking statements, which speak only as of the date made.
DHC does not undertake or accept any obligation or undertaking to
release publicly any updates or revisions to any forward-looking
statements to reflect any change in its expectations or any change
in events, conditions or circumstances on which any such statement
is based.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231128215767/en/
Investors: Ryan Flanagan, ICR
ryan.flanagan@icrinc.com
Media: Dan Brennan, ICR dan.brennan@icrinc.com
DHC Acquisition (NASDAQ:DHCA)
Historical Stock Chart
From May 2024 to Jun 2024
DHC Acquisition (NASDAQ:DHCA)
Historical Stock Chart
From Jun 2023 to Jun 2024